Richard Allman

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 14

Top Topics

Arterial Hypertension

Breast Cancer Risk

Atomic Force Microscopy

Cardiovascular Disease

Top Venues

Breast cancer research and treatment

Epidemiology and infection

This page only lists publications with an associated author ORCID identifier.

Publications

Erika L Spaeth, Gillian S Dite, John L Hopper, Richard Allman
Validation of an abridged breast cancer risk prediction model for the general population. Cancer prevention research (Philadelphia, Pa.) (2023)
Richard Allman, Yi Mu, Gillian S Dite, Erika L Spaeth, John L Hopper, Bernard A Rosner
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk. Breast cancer research and treatment (2023)
Richard Allman, Yi Mu, Gillian S Dite, Erika L Spaeth, John L Hopper, Bernard A Rosner
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk. Breast cancer research and treatment 198 (2) (2023)
Richard Allman, Yi Mu, Gillian S Dite, Erika L Spaeth, John L Hopper, Bernard A Rosner
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk. Breast cancer research and treatment 198 (2) (2023)
Richard Allman, Yi Mu, Gillian S Dite, Erika L Spaeth, John L Hopper, Bernard A Rosner
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk. Breast cancer research and treatment (2023)
Richard Allman, Yi Mu, Gillian S Dite, Erika L Spaeth, John L Hopper, Bernard A Rosner
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk. Breast cancer research and treatment 198 (2) (2023)
Gillian S Dite, Erika L Spaeth, Nicholas M Murphy, Richard Allman
Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk. The Prostate (2023)
Richard Allman, Yi Mu, Gillian S Dite, Erika L Spaeth, John L Hopper, Bernard A Rosner
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk. Breast cancer research and treatment 198 (2) (2023)
Richard Allman, Yi Mu, Gillian S Dite, Erika L Spaeth, John L Hopper, Bernard A Rosner
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk. Breast cancer research and treatment 198 (2) (2023)
Richard Allman, Yi Mu, Gillian S Dite, Erika L Spaeth, John L Hopper, Bernard A Rosner
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk. Breast cancer research and treatment 198 (2) (2023)
Gillian S Dite, Nicholas M Murphy, Erika L Spaeth, Richard Allman, null null
Validation of a clinical and genetic model for predicting severe COVID-19. Epidemiology and infection (2022)
Chi Kuen Wong, Enes Makalic, Gillian S Dite, Lawrence Whiting, Nicholas M Murphy, John L Hopper, Richard Allman
Polygenic risk scores for cardiovascular diseases and type 2 diabetes. PloS one 17 (12) (2022)
Aviv Gafni, Gillian S Dite, Erika Spaeth Tuff, Richard Allman, John L Hopper
Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank. PloS one 16 (9) (2021)
Gillian S Dite, Nicholas M Murphy, Richard Allman
Development and validation of a clinical and genetic model for predicting risk of severe COVID-19. Epidemiology and infection 149 (2021)